Radboud University Medical Center
π³π±Netherlands
- Country
- π³π±Netherlands
- Ownership
- Private
- Established
- 1951-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.radboudumc.nl
Efficacy Study of Ξ9-THC to Treat Chronic Abdominal Pain
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-03-18
- Last Posted Date
- 2013-07-09
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 24
- Registration Number
- NCT01318369
- Locations
- π³π±
Radboud University Nijmegen Medical Centre, Nijmegen, Gelderland, Netherlands
The Qure Study: Q-fever Fatigue Syndrome - Response to Treatment
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-03-18
- Last Posted Date
- 2021-06-23
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 156
- Registration Number
- NCT01318356
- Locations
- π³π±
Radboud university medical center, Nijmegen, Gelderland, Netherlands
Delta-THC in Behavioral Disturbances in Dementia
- First Posted Date
- 2011-02-24
- Last Posted Date
- 2014-01-22
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 22
- Registration Number
- NCT01302340
- Locations
- π³π±
Radboud university medical center, Nijmegen, Gelderland, Netherlands
π³π±Vincent van Gogh Institute for Psychiatry, department of Elderly, Venray, Limburg, Netherlands
Can Dipyridamole Induce Protection Against Ischemia and Reperfusion Injury in Patients Undergoing Elective Coronary Artery Bypass Grafting (CABG)?
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-02-14
- Last Posted Date
- 2013-01-10
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 95
- Registration Number
- NCT01295567
- Locations
- π³π±
RUNMC, Nijmegen, Netherlands
Autophagy Inhibition Using Hydrochloroquine in Breast Cancer Patients
- First Posted Date
- 2011-02-09
- Last Posted Date
- 2012-01-20
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT01292408
- Locations
- π³π±
University Medical Centre Nijmegen, Nijmegen, Gelderland, Netherlands
Multi-modality Imaging in the Prediction of Response to Systemic Treatment in Colorectal Cancer
- First Posted Date
- 2011-02-09
- Last Posted Date
- 2011-09-08
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT01292681
- Locations
- π³π±
Radboud University Nijmegen Medical Centre, Nijmegen, Gelderland, Netherlands
Pharmacokinetic Study of the HCV Protease Inhibitor Boceprevir and the HIV Integrase Inhibitor Raltegravir
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-02-02
- Last Posted Date
- 2020-12-01
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 24
- Registration Number
- NCT01288417
- Locations
- π³π±
CRCN, Nijmegen, Netherlands
Effect of Anakinra on Insulin Sensitivity in Type 1 Diabetes Mellitus
- First Posted Date
- 2011-01-27
- Last Posted Date
- 2011-04-14
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 16
- Registration Number
- NCT01285245
- Locations
- π³π±
Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
The Effect of Anakinra on Insulin Secretion
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2011-01-27
- Last Posted Date
- 2012-03-26
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 16
- Registration Number
- NCT01285232
- Locations
- π³π±
Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
Efficacy and Safety of Canakinumab in Schnitzler Syndrome
- First Posted Date
- 2011-01-13
- Last Posted Date
- 2012-05-24
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 8
- Registration Number
- NCT01276522
- Locations
- π³π±
Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
Β© Copyright 2024. All Rights Reserved by MedPath